Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China's Residents Health Card Offers Potential For Massive Data Mining

This article was originally published in PharmAsia News

Executive Summary

China plans to issue electronic medical cards to 50% of its residents by the end of the year in a new commitment to overhaul the country's healthcare system and strengthen capacity to handle the sheer volume of Chinese patients

You may also be interested in...



“Smart Healthcare” Initiatives Underscore Mobile Health Push In China

Mobile health implementation is expected to roll out in large hospitals in China, fundamentally changing how patients, service providers and suppliers interact.

Could NICE Pilot Projects Be An Opportunity For Multinationals In China’s County Hospital Market?

In a bid to control overspending and improve healthcare service quality in rural areas, the Chinese government is piloting health technology assessment projects in county-level hospitals, armed with technical support from the UK’s NICE.

FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg

FDA is considering further “modulations” of its current approaches to drug approvals in order to encourage innovation and get products to market more quickly, Commissioner Margaret Hamburg commented during a panel session at the Biotechnology Industry Organization International Convention in Washington, D.C. on June 28.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC078881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel